Magazine Article | July 5, 2018

Recent Changes May Reshape Financial Reporting In The Life Sciences Industry

Source: Life Science Leader

By Jeffrey Ellis and Dennis Howell

Changes in technology are creating transformative opportunities for life sciences companies. Artificial intelligence is helping to streamline the drug discovery process by analyzing large data sets from clinical trials. Gene therapy promises customized, targeted patient treatment. And blockchain technology could disrupt the supply chain by allowing companies to trace drugs from manufacturer to end consumer, which could improve drug safety and provide greater visibility of drugs within the channel.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: